David Kirn
2019
In 2019, David Kirn earned a total compensation of $554.3K as Chief Executive Officer at 4D Molecular Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $111,800 |
|---|---|
| Salary | $430,000 |
| Other | $12,500 |
| Total | $554,300 |
Kirn received $430K in salary, accounting for 78% of the total pay in 2019.
Kirn also received $111.8K in non-equity incentive plan and $12.5K in other compensation.
Rankings
In 2019, David Kirn's compensation ranked 11,444th out of 13,971 executives tracked by ExecPay. In other words, Kirn earned more than 18.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,444 out of 13,971 | 18th |
Division Manufacturing | 4,632 out of 5,695 | 19th |
Major group Chemicals And Allied Products | 1,824 out of 2,194 | 17th |
Industry group Drugs | 1,570 out of 1,880 | 17th |
Industry Biological Products, Except Diagnostic Substances | 346 out of 389 | 11th |
Source: SEC filing on April 6, 2021.
Kirn's colleagues
We found one more compensation record of an executive who worked with David Kirn at 4D Molecular Therapeutics in 2019.
2019
August Moretti
4D Molecular Therapeutics
Chief Financial Officer
News
4D Molecular Therapeutics CEO David Kirn's 2023 pay jumps 213% to $10M
April 10, 2024
4D Molecular Therapeutics CEO David Kirn's 2022 pay falls 37% to $3.3M
April 12, 2023
4D Molecular Therapeutics CEO David Kirn's 2021 pay jumps 641% to $5.2M
April 13, 2022
4D Molecular Therapeutics Chief Medical Officer Robert Fishman receives $3.3M in 2020
April 6, 2021